Esperion Therapeutics
ESPR
#6676
Rank
NZ$1.47 B
Marketcap
NZ$5.72
Share price
0.00%
Change (1 day)
33.07%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Last known market cap: NZ$1.47 Billion

As of November 2026 Esperion Therapeutics has a market cap of NZ$1.47 Billion. This makes Esperion Therapeutics the world's 6676th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.47 B-10.93%
2025NZ$1.65 B107.61%
2024NZ$0.79 B48.15%
2023NZ$0.53 B-25.64%
2022NZ$0.72 B62.19%
2021NZ$0.44 B-52.26%
2020NZ$0.93 B-61.64%
2019NZ$2.43 B32.35%
2018NZ$1.83 B-24.26%
2017NZ$2.42 B495.78%
2016NZ$0.40 B-44.34%
2015NZ$0.73 B-30.25%
2014NZ$1.04 B309.35%
2013NZ$0.25 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$301.71 B 20,384.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$178.38 B 12,011.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ$3.05 B 107.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ$1.49 B 1.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.17 B 455.22%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$20.30 B 1,278.73%๐Ÿ‡บ๐Ÿ‡ธ USA